N/A
N=60
Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI
Dyspnea
Bottom Line
View on ClinicalTrials.gov: NCT02395991 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
May 2021
Primary outcome: Primary: Number of Participants With Transient Dyspnea. — 23 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- gadoxetic acid (Drug); Magnetic resonance imaging (MRI) (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Seoul National University Hospital
- Primary completion
- Oct 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Transient Dyspnea. |
23 | — |
| SECONDARY Duration of Transient Dyspnea in Participants With Transient Dyspnea. |
21.5 | — |
Summary
The purpose of this study is to observe transient dyspnea pattern after Gd-EOB-DTPA administration by obtaining continuous dynamic T1 weighted image data.
Eligibility Criteria
Inclusion Criteria
- Patients who are referred to MR unit for hepatocyte-specific contrast enhanced liver MRI using gadoxetic acid, to characterize focal liver lesion or to investigate diffuse liver disease
- OR, Liver living donor candidates
- AND subjects who sign the informed consent.
Exclusion Criteria
- Minors under 18 years old
- All contraindication to MRI
- Hypersensitivity to Gd
- Biliary obstruction
Data sourced from ClinicalTrials.gov (NCT02395991). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.